logo +1-626-295-2442(Worldwide) 400-606-8865(China)
menu Sign in Register
english English

Global Demineralized Allografts Market Will Reach 940 Million USD by 2022

Author: QYResearch | Publish date: 2018-06-07 | Views: 15
Demineralized Allografts is tissue harvested from one individual and implanted into another of the same species. In a search for an adequate substitute for autogenous bone, cadaveric allograft has been a viable option. Structural and morselized forms are available and prepared as either fresh-frozen or freeze-dried. These grafts provide a structural framework or scaffold for host tissue to grow, hence making allograft osteoconductive. Conversely, its osteoinductive properties are mediocre at best. Upon implantation, the host is expected to experience an intricate immune response. Freezing or freeze-drying the allograft is crucial in minimizing this reaction; however, the fundamental properties of the material may be altered.

image.png

In the last several years, global market of demineralized allografts developed rapidly, with an average growth rate of 9%. In 2016, global revenue of demineralized allografts is nearly 567 M USD; the actual production is about 16.9 million units.

 

The global average price of demineralized allografts is in the decreasing trend, from 34.9 USD/Unit in 2012 to 33.4 USD/Unit in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.

 

The classification of demineralized allografts includes gel, putty and putty with chips, and the proportion of putty in 2016 is about 46%, and the proportion is in decreasing trend from 2012 to 2016.

 

Demineralized allografts are widely used in dental, spine surgery and trauma surgery. The most proportion of demineralized allografts is trauma surgery, and the consumption proportion is about 42%.

 

North America region is the largest supplier of demineralized allografts, with a production market share nearly 90% in 2016. Europe is the second largest supplier of demineralized allografts, enjoying production market share nearly 8% in 2016.

 

North America is the largest consumption place, with a consumption market share nearly 45% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 39%.

 

Market competition is intense. Medtronic, J &J (DePuy Synthes), Zimmer, Stryker Corporation, Straumann, RTI Surgical, Surgical Esthetics are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

The Global Demineralized Allografts Market Research Report 2018 report released by QYResearch provides a basic overview of the Demineralized Allografts industry, including definition, classification, application and industrial chain structure. Discuss development policies and plans as well as manufacturing processes and cost structures.

 

The report then focuses on major industry players in Global, including company profiles, product images and specifications, sales, market share, and contact information. More importantly, the Demineralized Allografts industry development trends and marketing channels were analyzed. Providing the main statistical data on the current status of the industry is a valuable guide and direction for companies and individuals interested in the market.

 

Click to view the full report

https://www.qyresearch.com/index/detail/87408/global-demineralized-allografts-market


CONTACT US
We will be happy to help you find what you're looking for. Please call or email us
  • China Office(Beijing): +86-1082945717
  • China Office(Hongkong): +852-30628839
  • China Office(Guangzhou): +86-2022093278
  • Japan Office: +81-9038009273; +81-345704342
  • South Korea Office: +82-10-7551-1278
  • Singapore Office: +65-31582122
  • India: +91-1140469822
Our clients
<
4321
>
>